JFL Life Sciences Limited IPO
JFL Life Sciences Limited was a SME IPO in the Pharmaceuticals sector, offered at ₹61–₹61 per share to raise ₹18 crore. It listed on 8 Sep 2022 at ₹70 and closed its first day at ₹66, a listing gain of +9.0% versus the ₹61 issue price. It now trades around ₹10 (-83.9% versus the issue price).
Frequently asked questions
- What were the JFL Life Sciences Limited IPO listing gains?
- JFL Life Sciences Limited listed on 8 Sep 2022 at ₹70, closing its first day at ₹66 — a listing gain of +9.0% versus the ₹61 issue price.
- What was the price band and lot size of the JFL Life Sciences Limited IPO?
- The price band was ₹61–₹61 per share, with a minimum lot of 2,000 shares (₹1,22,000 at the upper band).
- Who were the registrar and lead manager for the JFL Life Sciences Limited IPO?
- KFin Technologies Limited was the registrar, and GYR Capital Advisors was the book-running lead manager.